CTNNB1 and major depressive disorder: Our approach was successful in that it identified both upstream regulators previously implicated in MDD, such as interleukin-636–38, tumor necrosis factor37, and β-catenin (CTNNB1)9, as well as novel genes such as ESR1, which was the top regulator (Fig. 1b).